Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro

doi:10.1016/0014-4827(74)90653-3

Experimental Cell Research

Volume 86, Issue 1, May 1974, Pages 95-105

https://doi.org/10.1016/0014-4827(74)90653-3 Get rights and content

Abstract

Mouse epidermal cells in monolayer culture retain many of the characteristics of differentiating epidermis in vivo. The addition of retinyl acetate dissolved in DMSO to the culture medium alters the direction of differentiation. Desmosome and tonofilament formation are inhibited. There is proliferation of Golgi complexes and endoplasmic reticulum. New or increased production of glycoprotein is suggested by cytochemical procedures. These effects are dose- and vehicle-dependent and require the continued presence of retinyl acetate. At a dose of 12.5 μg/ml of culture medium, retinyl acetate inhibits DNA synthesis. Retinyl acetate or a metabolite remains in the cells for more than 7 days after a single 18 h exposure.

References (25)

SH Yuspa et al.
Chem biol interactions
(1969/1970)
SH Yuspa et al.
J invest derm
(1970)
MA Karasek et al.
J invest derm
(1971)
L DeLuca et al.
Exptl cell res
(1974)
OA Bessey et al.
J biol chem
(1946)
ML Barnett et al.
Exptl cell res
(1973)
JA Lucy
Am j clin nutr
(1969)
JP Mack et al.
Biochim biophys acta
(1972)
RR Bates et al.
J natl cancer inst
(1970)
H Hennings

FL Vaughn et al.

J invest derm

(1971)

CC Harris et al.

J natl cancer inst

(1972)

Cited by (391)

Immune tolerance of tissue-engineered skin produced with allogeneic or xenogeneic fibroblasts and syngeneic keratinocytes grafted on mice
2019, Acta Biomaterialia
Organs are needed for the long-term replacement of diseased or wounded tissues. Various technologies based on cells seeded in synthetic or biomaterial scaffolds, or scaffold-free methods have been developed in order to produce substitutes that mimic native organs and tissues. For cell-based approaches, the use of living allogeneic fibroblasts could potentially lead to the production of “off-the-shelf” bioengineered organs/tissues. However, questions remain regarding the outcome of allogeneic grafts in terms of persistence of allogeneic cells, tolerance and the host immune reaction against the tissue after implantation. To evaluate graft tolerance of engineered-tissues containing non-autologous fibroblasts, tissue-engineered skin substitutes (TESs) produced with syngeneic, allogeneic or xenogeneic fibroblasts associated with syngeneic, allogeneic or xenogeneic epithelial cells were grafted in mice as primary and secondary grafts. The immune response was evaluated by histological analysis and immunodetection of M2 macrophages, CD4- and CD8-positive T cells, 15, 19, 35 and 56 days after grafting. Tissue-engineered skin composed of non-autologous epithelial cells were rejected. In contrast, TESs composed of non-autologous fibroblasts underlying syngeneic epithelial cells were still present 56 days after grafting. This work shows that TES composed of non-autologous fibroblasts and autologous epithelial cells are not rejected after grafting.
We found that tissue-engineered skin substitutes produced by a scaffold-free cell-based approach from allogeneic fibroblasts and autologous epithelial cells are not rejected after grafting and allow for the permanent coverage of a full-thickness skin wounds. In the field of tissue engineering, these findings open the possibility of selecting a human fibroblastic or stromal cell population based on its biological properties and adequate biosafety, banking it, in order to produce “ready-to-use” bioengineered organs/tissues that could be grafted to any patient without eliciting immune reaction after grafting. Our results can be generalized to any organs produced from fibroblasts. Thus, it is a great step with multiple applications in tissue engineering and transplantation.
Involvement of HMGB1 and RAGE in IL-1β-induced gingival inflammation
2012, Archives of Oral Biology
Citation Excerpt :
Human primary epithelial and fibroblast cells were prepared from healthy gingival tissues from donors (n = 3) with their informed consent. Briefly, the gingiva was treated with 0.025% trypsin and 0.02% EDTA overnight at 4 °C and epithelial and fibroblast cells were isolated.18 The cell suspension was centrifuged at 120 × g for 5 min, and the pellet was suspended in medium for epithelial cells containing 0.4% V/V bovine pituitary extract, 10 μg/ml insulin, 0.1 ng/ml hEGF, 0.5 μg/ml hydrocortisone, 50 μg/ml gentamicin and 50 ng/ml amphotericin B (HuMedia-KG2, KURABO, Tokyo, Japan) and for fibroblasts in DMEM/10%FBS.
Extracellularly released high mobility group box 1 (HMGB1) protein behaves as a cytokine, promotes inflammation and participates in the pathogenesis of several disorders in peripheral organs. The role of HMGB1 and receptor for advanced glycation end products (RAGE) expressed in gingival inflammatory tissues was explored.
Real time PCR was applied to assay HMGB1 and RAGE mRNA expression in gingival epithelial and fibroblast cells induced by interleukin-1β (IL-1β). A highly selective inhibitor of inducible nitric oxide (iNOS) was employed. ELISA was done for measurement of HMGB1 concentrations in cell culture media of gingival epithelial and fibroblast cells. Immunohistochemistry was performed to analyse the expression and sub-cellular localization of HMGB1, together with RAGE, in specimens obtained from patients with chronic inflammation.
A time-dependent response of HMGB1 and RAGE expression in gingival cells to IL-1β induction was observed. IL-1β promotes HMGB1 production in human gingival epithelial cells in a nitric oxide-dependent manner. HMGB1 and RAGE appeared highly expressed in gingival inflammatory tissues.
These results demonstrate that HMGB1 and RAGE are abundantly expressed in gingiva and promptly released during gingival inflammation. We suggest a role for HMGB1/RAGE/iNOS signalling on inflamed gingival epithelial cells.
Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo
2011, European Journal of Pharmaceutics and Biopharmaceutics
A series of polyethylenimine (PEI) and γ-polyglutamic acid (PGA) nanocomposites (PPGA) was prepared and evaluated in terms of their cell viability and transfection efficiency in vitro and in vivo. On complexion with pDNA, the positively charged PPGA/DNA nanocomposites resulted in a higher level of in vitro reporter gene transfection (2.7–7.9-fold) as compared to native PEI, and selected commercial reagents and >95% cell viability in HEK293, HeLa and HepG2 cell lines. Further, PPGA-5 nanocomposite (the best working system in terms of transfection efficiency among the series) was found to efficiently transfect primary mouse keratinocytes up to 22% above the control level. PPGA-5, when tested for in vivo cytotoxicity in Drosophila, did not induce any stress in the exposed larvae in comparison with control. In vivo gene expression using PPGA-5 showed the highest transfection efficiency in spleen of mouse closely followed by heart tissues after intravenous injection through tail vein. Besides, these nanocomposites also delivered siRNA efficiently into mammalian cells, resulting in ∼80% suppression of EGFP expression. These results together demonstrated the potential of the projected nanocomposites for in vivo gene delivery.
Gellan gum blended PEI nanocomposites as gene delivery agents: Evidences from in vitro and in vivo studies
2011, European Journal of Pharmaceutics and Biopharmaceutics
Citation Excerpt :
One to two-day-old pups (4–5 nos.) were used for establishing primary cultures of keratinocytes, as described previously [19,20]. Briefly, these pups were euthanized and washed in 70% ethanol.
Branched Polyethylenimine, 25 kDa (PEI), was blended with gellan gum, an anionic heteropolysaccharide, for partial neutralization of its excess positive charge to form gellan gum-polyethylenimine (GP) nanocomposites (NCs). Subsequently, we manipulated the amount of gellan gum for obtaining a series of NCs and characterized them for their size, charge and morphology. Among all the NCs, one member, named GP3, showed the best transfection efficiency in tested cell lines in comparison with the rest of the series, PEI, Lipofectamine and other commercial transfection agents and also exhibited minimum cytotoxicity. It was found to transfect primary cells of mouse skin with better efficiency than PEI and Lipofectamine and was able to protect the plasmid DNA from nucleases and serum proteins present in the blood. GP3 exhibited efficient intracellular delivery of plasmid as revealed by confocal studies while its intracellular presence was also confirmed by the knockdown of GFP expression (using GFP specific siRNA) and JNKII by quantifying proteins in cell lysates and by western blotting and hybridization, respectively. In vivo cytotoxicity studies in Drosophila showed lack of induction of stress response in the exposed organisms. Further, exposed organisms did not show any developmental delay or mortality and no morphological defects were observed in the emerged flies. In vivo gene expression studies in Balb/c mice revealed maximum expression of luciferase enzyme in spleen. The study suggests that GP3 may act as an efficient non-viral gene carrier with diverse biomedical applications.
Loss of adiponectin promotes intestinal carcinogenesis in min and wild-type mice
2011, Gastroenterology
Metabolic syndrome- and obesity-associated cancers, including colon cancer, are common in Western countries. Visceral fat accumulation and decreased levels of plasma adiponectin (APN) have been associated with development of human colorectal adenoma. We investigated the function of APN in intestinal carcinogenesis.
APN^+/+, APN^+/−, or APN^−/− mice (C57BL/6J) were given injections of azoxymethane (AOM), which led to development of intestinal tumors; these strains of mice were also crossed with Min mice to assess polyp formation. Adipocytokine levels and phosphorylation/activation of AMP-activated protein kinase (AMPK) were evaluated to investigate the mechanisms of APN in tumor growth.
The total number of polyps in the intestines of male APN^+/− Min and APN^−/−Min mice increased 2.4- and 3.2-fold, respectively, by the age of 9 weeks and 3.2- and 3.4-fold, respectively, by 12 weeks, compared with those of APN^+/+Min mice. Similar results were obtained from female mice. AOM induced colon tumor formation in 40% of APN^+/+, 50% of APN^+/−, and 71% of APN^−/− (P < .05) mice, respectively; mean values for tumor multiplicity of each genotype were 0.5, 0.6, and 1.1 (P < .05), respectively. Phosphorylation of AMPK decreased in intestinal epithelial cells of APN^−/− mice compared with APN^+/+ mice. Among serum adipocytokines, plasminogen activator inhibitor−1 levels increased in APN^−/−Min mice and APN^−/− mice that received injections of AOM. Activation of AMPK suppressed expression of plasminogen activator inhibitor−1 in Min mice.
Mice with disruptions in APN develop more intestinal tumors and have decreased activation (phosphorylation) of AMPK and increased levels of plasminogen activator inhibitor−1, compared with wild-type mice. APN and its receptor might be developed as targets for cancer chemopreventive agents.
17β-estradiol inhibits wound healing in male mice via estrogen receptor-α
2010, American Journal of Pathology
Citation Excerpt :
Total cellular RNA and protein samples were subsequently isolated and analyzed by qPCR and immunoblotting/zymography. Male and female mouse neonates were euthanized by decapitation and their trunk skin removed and rinsed in 70% ethanol.16 The epidermis was loosened from the dermis through overnight incubation in 5 mg/ml dispase I (Sigma-Aldrich) at 4°C.
Although estrogens have long been known to accelerate healing in females, their roles in males remain to be established. To address this, we have investigated the influence of 17β-estradiol on acute wound repair in castrated male mice. We report that sustained exposure to estrogen markedly delays wound re-epithelialization. Our use of hairless mice revealed this response to be largely independent of hair follicle cycling, whereas other studies demonstrated that estrogen minimally influences wound inflammation in males. Additionally, we report reduced collagen accumulation and increased gelatinase activities in the wounds of estrogen-treated mice. Increased wound matrix metalloproteinase (MMP)-2 activity in these animals may i) contribute to their inability to heal skin wounds optimally and ii) stem, at least in part, from effects on the overall levels and spatial distribution of membrane-type 1-MMP and tissue inhibitor of MMP (TIMP)-3, which respectively facilitate and prevent MMP-2 activation. Using mice rendered null for either the α or β isoform of the estrogen receptor, we identified estrogen receptor-α as the likely effector of estrogen’s inhibitory effects on healing.

View all citing articles on Scopus

View full text

Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro

Abstract

Chem biol interactions

J invest derm

J invest derm

Exptl cell res

J biol chem

Exptl cell res

Am j clin nutr

Biochim biophys acta

J natl cancer inst

J invest derm

J natl cancer inst